GlassScriptPhysician profile
Steven M Lucas
NPI 1821292616
$2,324.93
in general payments reported to CMS, 2019-2025
34 companies · $1,183 in 2025
The $1,183 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $99.40 · 2021: $200 · 2022: $264 · 2023: $156 · 2024: $224 · 2025: $1,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.18 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $207.07 | 2020-2025 | |
| Janssen Biotech, INC. | $200.81 | 2022-2025 | Tremfya, Erleada, Simponi |
| Boston Scientific Corporation | $188.13 | 2019-2022 | |
| Calyxo, INC. | $156.16 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $127.72 | 2021-2024 | |
| Abbvie INC. | $123.08 | 2022-2025 | |
| Janssen Scientific Affairs, LLC | $117.76 | 2025 | |
| Medtronic, INC. | $112.92 | 2023-2025 | Interstim |
| Blue Earth Diagnostics | $109.21 | 2019-2025 | Posluma |
| Immunitybio, INC. | $107.08 | 2025 | |
| Ferring Pharmaceuticals INC. | $106.71 | 2025 | Adstiladrin |
| Smith+Nephew, INC. | $87.98 | 2025 | Grafix, Stravix, Stravix Pl |
| Teleflex LLC | $73.91 | 2022-2025 | Urolift |
| Merck Sharp & Dohme LLC | $65.91 | 2022-2024 | Keytruda |
| Urogen Pharma, INC. | $61.91 | 2021-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $57.68 | 2020-2025 | Vistaseal, Stratafix, Echelon Endopath |
| Dentsply Ih Ab | $52.40 | 2023-2025 | Lofric, Lofric |
| Dentsply Ih INC. | $44.84 | 2020-2021 | |
| Allergan, INC. | $42.41 | 2021 | |
| Axonics, INC. | $31.52 | 2022-2023 | Bulkamid |
| Olympus America INC. | $30.35 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $28.54 | 2025 | |
| Acera Surgical, INC. | $22.98 | 2025 | Restrata Wound Matrix |
| Helsinn Therapeutics (U.S.), INC. | $22.29 | 2025 | Valchlor |
| Convatec INC. | $21.23 | 2023 | |
| Endo Pharmaceuticals INC. | $18.63 | 2022 | |
| Cook Medical LLC | $16.35 | 2021 | |
| Amgen INC. | $15.77 | 2020 | |
| Procept Biorobotics Corporation | $15.64 | 2023 | Aquabeam Robotic System |
| Photocure INC | $14.39 | 2021 | |
| Laborie Medical Technologies Corp. | $12.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Covidien LP | $11.49 | 2019 | |
| Ambu INC. | $8.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.